Browse By: Country ι Category ι Publisher ι Tag

Biopharmaceutical Market Research Reports

Biopharmaceutical Outsourcing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Biopharmaceutical industry is one of the major contributors in global economic progress. Due to globalization, outsourcing of the biopharmaceutical processes has increased to great extent. Complexity of processes and technology oriented industry companies started finding it feasible for outsourcing processes to experts. Outsourcing also helped corporate in cost reduction and better focus on core business segments. Once considered as a cost saving alternative, outsourcing of biopharmaceutical business is now a strategic decision.  Biopharmaceutical market is very competitive and global players occupying majority of market share operate in same geographies. Although advent of generics is an opportunity for small pharma companies, it is major threat to branded drug manufa
Published Date: Sep 2024
Published By: Transparency Market Research

Price: $4795
Single-Use Technologies For Biopharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Single use technologies involve single-use or disposable products. Such products are usually made of plastics or its derivatives such as polyamides, polycarbonates, polyethylene, polyvinyl chloride and various others. These products are becoming popular in the biopharmaceutical applications as they reduce the overall chances of contaminations and drastically reduce manufacturing and maintenance cost. They also provide benefits of being pre-assembled, sterile, and reduce operation time. Various disposable products available for biopharmaceutical use are laboratory instruments like flasks, petri plates, cell culture apparatus, filling and tubing systems, pumps, filters, bioreactors and others.   The global market can be segmented as follows: By Culture Systems Petriplates Fl
Published Date: Dec 2023
Published By: Transparency Market Research

Price: $4795
US Biopharmaceutical Market - Global Industry Size, Market Share, Smart Trends, Analysis And Forecast, 2012 - 2018
Biopharmaceuticals are medical drugs which are produced with the help of biotechnology. The US is the largest market for biopharmaceuticals and is the leader in terms of revenue, by a substantial margin. The biopharmaceutical market can be classified based on the class of the medical drug into recombinant proteins, monoclonal antibodies and purified proteins. Based on the therapeutic applications, biopharmaceuticals can be classified as blood factors, thrombolytic agents, hormones, hematopoietic growth factors, interferon’s and vaccines.  The US biopharmaceutical market was valued at USD 90 billion and is estimated to grow with a CAGR of 11%. The US accounts for more than half the production of biopharmaceuticals in the world. The biopharmaceutical market is expect
Published Date: Jan 2019
Published By: Transparency Market Research

Price: $4795
RegeneRx Biopharmaceuticals, Inc. - Product Pipeline Review - 2014
Global Markets Directs, RegeneRx Biopharmaceuticals, Inc. Product Pipeline Review 2014, provides an overview of the RegeneRx Biopharmaceuticals, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of RegeneRx Biopharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The rep
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
XTL Biopharmaceuticals Ltd. - Product Pipeline Review - 2014
XTL Biopharmaceuticals Ltd. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, XTL Biopharmaceuticals Ltd. - Product Pipeline Review - 2014, provides an overview of the XTL Biopharmaceuticals Ltd.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of XTL Biopharmaceuticals Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy ar
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $1500
Eiger BioPharmaceuticals, Inc. - Product Pipeline Review - 2014
Eiger BioPharmaceuticals, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Eiger BioPharmaceuticals, Inc. - Product Pipeline Review - 2014, provides an overview of the Eiger BioPharmaceuticals, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Eiger BioPharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 2
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $1500
Paras Biopharmaceuticals Finland Oy - Product Pipeline Review - 2014
Paras Biopharmaceuticals Finland Oy - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Paras Biopharmaceuticals Finland Oy - Product Pipeline Review - 2014, provides an overview of the Paras Biopharmaceuticals Finland Oys pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Paras Biopharmaceuticals Finland Oys, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across g
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $1500
Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2014
Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2014, provides an overview of the Asklepios BioPharmaceutical, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Asklepios BioPharmaceutical, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe cov
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $1500
Alder Biopharmaceuticals Inc. - Product Pipeline Review - 2014
Alder Biopharmaceuticals Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Alder Biopharmaceuticals Inc. - Product Pipeline Review - 2014, provides an overview of the Alder Biopharmaceuticals Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Alder Biopharmaceuticals Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 th
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $1500
Lyophilization Equipment and Services Market (Equipment: Bench-top Lyophilizers, Tray Lyophilizers, Rotary Lyophilizers, Freeze Drying Microscopes ; Services: Cycle Development, Aseptic Filling, Bulk Lyophilization (Freeze Drying) & Applications: Pharmaceuticals, Biopharmaceuticals, Diagnostics & Nutraceuticals) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
This report provides an in-depth analysis of the lyophilization equipment and services market across various regions. A detailed analysis of the market forecast in terms of annual revenue, in USD millions, is provided for the period 2014 to 2020, considering 2013 as the base year. Lyophilization equipment and services market is expected to grow rapidly with rising opportunities in emerging markets such as China, India, Mexico and Brazil and an increase in demand of technologically advanced services in the biopharmaceutical, nutraceuticals and pharmaceutical industries.   The executive summary of this report provides a market snapshot with details about various segments in the lyophilization equipment and services market. The market dynamics such as drivers, restraints and opportu
Published Date: Oct 2014
Published By: Transparency Market Research

Price: $4795
NGM Biopharmaceuticals, Inc. - Product Pipeline Review - 2014
NGM Biopharmaceuticals, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, NGM Biopharmaceuticals, Inc. - Product Pipeline Review - 2014, provides an overview of the NGM Biopharmaceuticals, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of NGM Biopharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therap
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2014
Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2014, provides an overview of the Genervon Biopharmaceuticals, LLCs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Genervon Biopharmaceuticals, LLCs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe coverin
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Biopharmaceuticals Markets in China
China\'s demand for Biopharmaceuticals has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China\'s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.
Published Date: Jun 2014
Published By: Asia Market Information & Development Company

Price: $4000
Global and China Biopharmaceuticals Industry 2014 Market Research Report
The report firstly introduced Biopharmaceuticals basic information included Biopharmaceuticals definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Biopharmaceuticals industry policy and plan, Biopharmaceuticals product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Biopharmaceuticals capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Biopharmaceuticals products customers application capacity market position company contact information etc company related information,
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Biopharmaceutical Companies (Global) - Industry Report
Plimsoll Publishing’s Biopharmaceutical Companies (Global) Analysis provides a detailed overview of the Biopharmaceutical Companies (Global) market and delivers a comprehensive individual analysis on the top 180 companies, including BAXTER INTERNATIONAL INC, DONG-A PHARMACEUTICAL CO.,LTD. and STALLERGENES SA.  This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Biopharmaceutical Companies (Global) analysis is ideal for anyone wanting to: See the market leaders Identify companies heading for failure Seek out the most attractive acquisition Analyse industry trends Benchmark their own financial performance Using Plimsoll’s exclusive methodology, a quick glance of
Published Date: Jan 2014
Published By: Plimsoll Publishing Ltd.

Price: $1425
SK Biopharmaceuticals Co., Ltd. - Product Pipeline Review - 2013
Global Market Directs pharmaceuticals report, SK Biopharmaceuticals Co., Ltd. Product Pipeline Review 2013 provides data on the SK Biopharmaceuticals Co., Ltd.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, SK Biopharmaceuticals Co., Ltd.s corporate website, SEC filings, investor presentations and featured press releases, both from SK Biopharmaceuticals Co., Ltd. and industry-specific third party sources, put together by Global Markets Directs team. Scope SK Biopharmaceuticals Co., Ltd. Brief SK Biopharmaceuticals Co., Ltd. overvi
Published Date: Dec 2013
Published By: Global Markets Direct

Price: $1500
Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2013
Global Market Directs pharmaceuticals report, Genervon Biopharmaceuticals, LLC Product Pipeline Review 2013 provides data on the Genervon Biopharmaceuticals, LLCs research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, Genervon Biopharmaceuticals, LLCs corporate website, SEC filings, investor presentations and featured press releases, both from Genervon Biopharmaceuticals, LLC and industry-specific third party sources, put together by Global Markets Directs team.  Scope Genervon Biopharmaceuticals, LLC Brief Genervon Biopharmaceuticals
Published Date: Dec 2013
Published By: Global Markets Direct

Price: $1500
Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2013
Global Market Directs pharmaceuticals report, Asklepios BioPharmaceutical, Inc. Product Pipeline Review 2013 provides data on the Asklepios BioPharmaceutical, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, Asklepios BioPharmaceutical, Inc.s corporate website, SEC filings, investor presentations and featured press releases, both from Asklepios BioPharmaceutical, Inc. and industry-specific third party sources, put together by Global Markets Directs team.  Scope Asklepios BioPharmaceutical, Inc. Brief Asklepios BioPharmaceu
Published Date: Dec 2013
Published By: Global Markets Direct

Price: $1500
XTL Biopharmaceuticals Ltd. - Product Pipeline Review - 2013
Global Market Directs pharmaceuticals report, XTL Biopharmaceuticals Ltd. Product Pipeline Review 2013 provides data on the XTL Biopharmaceuticals Ltd.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, XTL Biopharmaceuticals Ltd.s corporate website, SEC filings, investor presentations and featured press releases, both from XTL Biopharmaceuticals Ltd. and industry-specific third party sources, put together by Global Markets Directs team. Scope XTL Biopharmaceuticals Ltd. Brief XTL Biopharmaceuticals Ltd. overview including business de
Published Date: Dec 2013
Published By: Global Markets Direct

Price: $1500
The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry
A  comparative analysis and assessment of TCR technologies, pipelines and  companies from an industry perspective Therapeutic monoclonal antibodies have become an  increasingly successful treatment modality with sales of US$ 65 bln in the year  2012 and with an average (continuous) annual growth rate from 2006 to 2012 of  18.9%. While antibody technologies are steadily evolving, the spectrum of  druggable targets for monoclonal antibodies has remained limited to  extracellular antigens, albeit including proteins, carbohydrates and  glycolipids.   Access to druggable, IP-protected and validated new targets  is a major bottleneck in the biopharmaceutical industry. Technologies which can  deliver both new targets and the correspondi
Published Date: Oct 2013
Published By: La Merie Publishing

Price: $1919
Eiger BioPharmaceuticals, Inc. - Product Pipeline Review - 2013
Global Market Directs pharmaceuticals report, Eiger BioPharmaceuticals, Inc. Product Pipeline Review 2013 provides data on the Eiger BioPharmaceuticals, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, Eiger BioPharmaceuticals, Inc.s corporate website, SEC filings, investor presentations and featured press releases, both from Eiger BioPharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Directs team. Scope Eiger BioPharmaceuticals, Inc. Brief Eiger BioPharmaceuticals, Inc. overview inc
Published Date: Aug 2013
Published By: Global Markets Direct

Price: $1500
Biopharmaceutical Licensing Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts, 2012 - 2018
The biopharmaceutical industry is focusing on the growing complexity of licensing deals in order to secure marketing and commercialization rights within partnership deals. The major challenge faced by the biopharmaceutical licensing market is asymmetry between licensor and licensees. The biopharmaceutical licensing industry is growing in popularity as large companies are becoming heavily dependent on alliances and licensing to gain access to newer technologies in the biopharmaceutical market.  This dependence has strengthened the bargaining position of smaller players as they are willing to expand their role beyond product discovery and development towards active participation in the biopharmaceutical products industry.  This research report on the biopharmaceutical licen
Published Date: Aug 2013
Published By: Transparency Market Research

Price: $4795
Alder Biopharmaceuticals Inc. - Product Pipeline Review - 2013
Global Market Directs pharmaceuticals report, Alder Biopharmaceuticals Inc. Product Pipeline Review 2013 provides data on the Alder Biopharmaceuticals Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, Alder Biopharmaceuticals Inc.s corporate website, SEC filings, investor presentations and featured press releases, both from Alder Biopharmaceuticals Inc. and industry-specific third party sources, put together by Global Markets Directs team. Scope Alder Biopharmaceuticals Inc. Brief Alder Biopharmaceuticals Inc. overview including
Published Date: Jun 2013
Published By: Global Markets Direct

Price: $1500
BioPharmaceutical Industry in China - An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges
BioPharmaceutical Industry in China - An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges” provides you with a detailed investigation of the market size, segmentation, key players, SWOT analysis, influential Government policies, and business and economic environments. The report is supported by over 154 tables & figures. The Chinese biopharmaceutical market is presented as follows: By Company (e.g., AMOYTOP BIOTECH, BEIJING CONTINENT PHARMACEUTICALS, FUSOGEN, SHANGHAI HUAGUAN BIOCHIP, SIBIONO GENETECH, ABBOTT, ROCHE, PFIZER, GSK, NOVARTIS) By Therapeutic Area (e.g., Anti-infective, Cancer, Diabetes, Dementia, Depression) A wealth of financial informatio
Published Date: May 2013
Published By: Kelly Scientific Publications

Price: $2593
R&D Productivity - The State of Research and Development in the BioPharmaceutical Industry
As blockbusters go off patent and the pool of marketed products supporting pharmaceutical Research & Development (R&D) decline, questions about the future of R&D in the pharmaceutical and biotech industry arise. Where will funding come from? Is spend decreasing? If spend is decreasing, what impact is this having on R&D? What can be done to encourage innovation in the biotech and pharmaceutical industry? Is the biotech model of R&D better for innovation than the traditional pharmaceutical model?Gauging the overall growth of R&D in the pharmaceutical and biotech industry proves challenging in regards to stipulating the appropriate definition of variables by which this is measured. Public companies may release overall expenses, yet allocations to specific products or franchises may be more di
Published Date: Apr 2013
Published By: CBR Pharma Insights

Price: $3900
Asklepios BioPharmaceutical, Inc. Product Pipeline Review 2012
Global Market Directs pharmaceuticals report, Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2012 provides data on the Asklepios BioPharmaceutical, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, Asklepios BioPharmaceutical, Inc.s corporate website, SEC filings, investor presentations and featured press releases, both from Asklepios BioPharmaceutical, Inc. and industry-specific third party sources, put together by Global Markets Directs team.  Scope Asklepios BioPharmaceutical, Inc. - Brief Asklepios BioP
Published Date: Dec 2012
Published By: Global Markets Direct

Price: $1500
Chinese Markets for Biopharmaceuticals
China\'s demand for biopharmaceuticals has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China\'s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in China are profiled.
Published Date: Nov 2012
Published By: Asia Market Information & Development Company

Price: $2000
Downstream Processing in Biopharmaceuticals - Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness
Downstream Processing in Biopharmaceuticals Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness GBI Research, the leading business intelligence provider, has released its latest research, Downstream Processing in Biopharmaceuticals Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness, which provides key data, information and analysis of the Contract Manufacturing Organization (CMO) industry, and the downstream processing and reagent market. The report provides comprehensive insight into the size of the CMO market, the downstream processing and reagent market and includes forecasts, key reasons for outsourcing, market characterization, downstream pr
Published Date: Nov 2012
Published By: GBI Research

Price: $3500
SK Biopharmaceuticals Co., Ltd. Product Pipeline Review 2012
SK Biopharmaceuticals Co., Ltd. Product Pipeline Review 2012 Global Market Directs pharmaceuticals report, SK Biopharmaceuticals Co., Ltd. Product Pipeline Review 2012 provides data on the SK Biopharmaceuticals Co., Ltd.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, SK Biopharmaceuticals Co., Ltd.s corporate website, SEC filings, investor presentations and featured press releases, both from SK Biopharmaceuticals Co., Ltd. and industry-specific third party sources, put together by Global Markets Directs team. Scope SK Biopharma
Published Date: Oct 2012
Published By: Global Markets Direct

Price: $1500
Inspiration Biopharmaceuticals, Inc. Product Pipeline Review 2012
Inspiration Biopharmaceuticals, Inc. Product Pipeline Review 2012 Global Market Directs pharmaceuticals report, Inspiration Biopharmaceuticals, Inc. Product Pipeline Review 2012 provides data on the Inspiration Biopharmaceuticals, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, Inspiration Biopharmaceuticals, Inc.s corporate website, SEC filings, investor presentations and featured press releases, both from Inspiration Biopharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Directs team.&n
Published Date: Oct 2012
Published By: Global Markets Direct

Price: $1500
Biopharmaceutical Manufacturing in India, China and South Korea - Regulatory Framework, Infrastructure Support and Discovery Funding Create an Environment Conducive to Growth
Biopharmaceutical Manufacturing in India, China and South Korea Regulatory Framework, Infrastructure Support and Discovery Funding Create an Environment Conducive to Growth GBI Research, the leading business intelligence provider has released its latest research report, Biopharmaceutical Manufacturing in India, China and South Korea Regulatory Framework, Infrastructure Support and Discovery Funding Create an Environment Conducive to Growth. The report provides an analysis of biopharmaceuticals approved in 2010 and 2011, operating dynamics in the biopharmaceutical industry, the current scenario in biopharmaceutical manufacturing, key stakeholders, the current market size (2011) of biopharmaceuticals, and forecasts to 2016 for India, China, South Korea and the global market. The repor
Published Date: Oct 2012
Published By: GBI Research

Price: $3500
RegeneRx Biopharmaceuticals, Inc. - Product Pipeline Review - 2012
RegeneRx Biopharmaceuticals, Inc. Product Pipeline Review 2012 Global Market Directs pharmaceuticals report, RegeneRx Biopharmaceuticals, Inc. Product Pipeline Review 2012 provides data on the RegeneRx Biopharmaceuticals, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, RegeneRx Biopharmaceuticals, Inc.s corporate website, SEC filings, investor presentations and featured press releases, both from RegeneRx Biopharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Directs team.  Scope
Published Date: Sep 2012
Published By: Global Markets Direct

Price: $1500
Accentia Biopharmaceuticals, Inc. - Product Pipeline Review - 2012
Accentia Biopharmaceuticals, Inc. Product Pipeline Review 2012 Global Market Directs pharmaceuticals report, Accentia Biopharmaceuticals, Inc. Product Pipeline Review 2012 provides data on the Accentia Biopharmaceuticals, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, Accentia Biopharmaceuticals, Inc.s corporate website, SEC filings, investor presentations and featured press releases, both from Accentia Biopharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Directs team.  Scope
Published Date: Sep 2012
Published By: Global Markets Direct

Price: $1500
Nabi Biopharmaceuticals - Product Pipeline Review - 2012
Nabi Biopharmaceuticals Product Pipeline Review 2012 Global Market Directs pharmaceuticals report, Nabi Biopharmaceuticals Product Pipeline Review 2012 provides data on the Nabi Biopharmaceuticalss research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, Nabi Biopharmaceuticalss corporate website, SEC filings, investor presentations and featured press releases, both from Nabi Biopharmaceuticals and industry-specific third party sources, put together by Global Markets Directs team.  Scope Nabi Biopharmaceuticals Brief Nabi Biopharmace
Published Date: Sep 2012
Published By: Global Markets Direct

Price: $1500
Eiger BioPharmaceuticals, Inc. - Product Pipeline Review - 2012
Eiger BioPharmaceuticals, Inc. Product Pipeline Review 2012 Global Market Directs pharmaceuticals report, Eiger BioPharmaceuticals, Inc. Product Pipeline Review 2012 provides data on the Eiger BioPharmaceuticals, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Directs proprietary databases, Eiger BioPharmaceuticals, Inc.s corporate website, SEC filings, investor presentations and featured press releases, both from Eiger BioPharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Directs team. Scope Eiger BioPharmace
Published Date: Sep 2012
Published By: Global Markets Direct

Price: $1500
Global Biopharmaceuticals Market 2011-2015
TechNavio's analysts forecast the Global Biopharmaceuticals market to grow at a CAGR of 4.9 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increased adoption of advanced technologies. The Global Biopharmaceuticals market has also been witnessing the trend of an increase in RandD activities. However, patent expiration of top-selling drugs could pose a challenge to the growth of this market. TechNavio's report, the Global Biopharmaceuticals Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Biopharmaceuticals landscape and its growth prospects in the coming years. The report also includ
Published Date: Jul 2012
Published By: Technavio

Price: $2004
Top 200 Biopharmaceutical Companies (Global)
This report is an in-depth financial evaluation of the GlobalBiopharmaceutical Companies. Using the unique Plimsoll method of analysis, each of the top 200 companies included is individually assessed and ranked against each other and compared to industry averages.Using the most up-to-date financial information available, the two-page per company analysis provides detailed financial analysis for each organisation. The following are some of the key findings of this new report:  85 of the 200 companies analysed have been rated as Danger 52 companies are ripe for takeover  123 companies achieved greater than 10% increase in sales last year. 78 companies made a pre-tax loss.  61 companies saw sales fall last year.  Our analysis gives you this unrivall
Published Date: Jul 2012
Published By: Plimsoll Publishing Ltd.

Price: $1500
Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries
GBI Research, the leading business intelligence provider, has released its latest research, Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries, which provides insights into global technology transfer strategies landscape.  The report explores the recognized and increasing need for a better understanding between all stakeholders in the biopharmaceutical and pharmaceutical community concerning the efficient transfer of technologies created from early innovative research to the commercialization of new product technologies. The report introduces the concept of technology transfer and the organizational reasons for opting on technology transfer along with the major technologies transferred.  It also pr
Published Date: May 2011
Published By: GBI Research

Price: $3500
Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market
GBI Research\'s report, Upstream Processing in Biopharmaceuticals - Increasing Use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market, provides the key to market data on overall upstream process, Contract Manufacturing Organization (CMO) market for upstream processing, and the cell culture and reagent market. Market.  The report also analyzes the strengths, weaknesses, opportunities, and threats for the key players in the CMO and cell culture and regent market. The report also discusses the key market drivers and restraints for the upstream processing, outsourcing to CMO and cell culture and reagent market. The report is based on proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts to pr
Published Date: Mar 2011
Published By: GBI Research

Price: $3500
Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies
GBI Research\'s report, “Down Stream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost-effective Purification Technologies”, provides the key data and analyzes the major challenges and drivers for the downstream industry. The report also analyzes the strengths, weaknesses of and opportunities for the stakeholders in the downstream processing of biopharmaceuticals.  The report also discusses the key market drivers and barriers for the growth of biomanufacturing in the pharmaceutical and biotech industry. The report is based on proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts to provide a comprehensive view of the Down Stream Processing in Biopharmace
Published Date: Nov 2010
Published By: GBI Research

Price: $3500
Pharmaceutical Mergers and Acquisitions - M&A in the Biopharmaceutical Industry and the Impact on Innovation
The history of the pharmaceutical industry is closely linked to the business practices of the combination and purchase of corporations. From the creation of the combined entity of Warner-Lambert in 1955, to the purchase of Warner-Lambert by Pfizer in 2000, to the recent acquisition of Wyeth, pharmaceutical and biotech companies have expanded their pipelines, portfolios, and sales forces through mergers and acquisitions (M&A).Mergers and Acquisitions have defined the landscape of the pharmaceutical and biotechnology industries, both historically and today. The strategic targeting behind corporate acquisitions, as well as mergers, are focused on intellectual property, sales force efficiency, streamlining research & development, and reorganizing other key business areas.This report provides a
Published Date: Sep 2009
Published By: CBR Pharma Insights

Price: $3900

Upcoming Reports

Effect Pigments Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Effect pigments are those that exhibit special effects to various substrates in order to enhance its quality and to make it comparatively attractive to consumers. These pigments display a wide range of properties such as an effect pigment can demonstrate color travel, they can reflect or refract lig
Published By: Transparency Market Research
Price: $4795
Solid State Batteries Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
Advancement in technology and materials has substantially increased the performance and reliability of battery systems. The liquid electrolytes used in conventional lithium-ion batteries are replaced by lithium metal electrodes in solid state batteries. As a result the solid state batteries are more
Published By: Transparency Market Research
Price: $4795
Marine Hybrid Propulsion Market - Global Industry Analysis, size, Share, Growth, Trends and Forecast 2014 - 2020
Hybrid propulsion combines 2 types of propulsions to propel a ship. All hybrid propulsion systems that exist at this moment combine a conventional propulsion system (combustion engines/turbines) with electrical propulsion, such as Azipods and Azipulls. Usually a hybrid propulsion system is just know
Published By: Transparency Market Research
Price: $4795
E-Waste Management Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
The global e-waste management market is anticipated to grow during the forecast period owing to the increasing amount of e-waste generated every year. The e-waste generated should be recycled or disposed properly to protect the environment and human beings from the harmful effects of toxic elements
Published By: Transparency Market Research
Price: $4795
LNG Re-Gasification Market - Global Industry Analysis, Market Size, Share, Growth, Trends and Forecast 2014 - 2020
Increase in the oil and gas exploration activities to satisfy the global energy needs can have direct implications on the global LNG Re-gasification industry. The global market for LNG Re-gasification industry depends upon the demand for LNG, and hence any factor driving LNG demand could also drive
Published By: Transparency Market Research
Price: $4795